Erste Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.1K | Hold |
31,400
| – | – | ﹤0.01% | 868 |
|
|
2025
Q1 | $48.7K | Hold |
31,400
| – | – | ﹤0.01% | 510 |
|
|
2024
Q4 | $68.8K | Hold |
31,400
| – | – | ﹤0.01% | 510 |
|
|
2024
Q3 | $91.4K | Hold |
31,400
| – | – | ﹤0.01% | 500 |
|
|
2024
Q2 | $76.6K | Hold |
31,400
| – | – | ﹤0.01% | 499 |
|
|
2024
Q1 | $140K | Hold |
31,400
| – | – | ﹤0.01% | 482 |
|
|
2023
Q4 | $103K | Hold |
31,400
| – | – | ﹤0.01% | 503 |
|
|
2023
Q3 | $107K | Hold |
31,400
| – | – | ﹤0.01% | 499 |
|
|
2023
Q2 | $144K | Hold |
31,400
| – | – | ﹤0.01% | 506 |
|
|
2023
Q1 | $156K | Hold |
31,400
| – | – | ﹤0.01% | 511 |
|
|
2022
Q4 | $187K | Hold |
31,400
| – | – | ﹤0.01% | 495 |
|
|
2022
Q3 | $324K | Hold |
31,400
| – | – | 0.01% | 467 |
|
|
2022
Q2 | $367K | Hold |
31,400
| – | – | 0.01% | 459 |
|
|
2022
Q1 | $294K | Sell |
31,400
-9,400
| -23% | -$87.9K | 0.01% | 483 |
|
|
2021
Q4 | $626K | Hold |
40,800
| – | – | 0.01% | 408 |
|
|
2021
Q3 | $1.05M | Hold |
40,800
| – | – | 0.02% | 336 |
|
|
2021
Q2 | $1.03M | Hold |
40,800
| – | – | 0.02% | 342 |
|
|
2021
Q1 | $1.36M | Hold |
40,800
| – | – | 0.03% | 313 |
|
|
2020
Q4 | $1.1M | Hold |
40,800
| – | – | 0.03% | 325 |
|
|
2020
Q3 | $1.54M | Hold |
40,800
| – | – | 0.05% | 274 |
|
|
2020
Q2 | $1.71M | Hold |
40,800
| – | – | 0.07% | 247 |
|
|
2020
Q1 | $819K | Buy |
+40,800
| New | +$819K | 0.05% | 276 |
|